Concepedia

Publication | Open Access

Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer

DOIFull Paper Access

63

Citations

32

References

2022

Year

Aya Shiba‐Ishii, Ted W. Johnson, Ibiayi Dagogo‐Jack, Mari Mino–Kenudson, Theodore R. Johnson, Ping Wei, Scott L. Weinrich, Michele McTigue, Makeba Walcott, Linh Nguyen-Phuong,
Nature Cancer

References

YearCitations

Page 1